Torren Management’s KalVista Pharmaceuticals KALV Stock Holding History

Torren Management’s Portfolio KALV Stock Details KALV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-119	Closed	-$2.4K	–	966
2026 Q1	$2.4K	Hold	119	–	–	﹤0.01%	506
2025 Q4	$1.92K	Buy	+119	New	+$1.58K	﹤0.01%	1073

Other funds holding KALV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Torren Management's KALV Position: Q2 2026 in Review

Torren Management sold out of KalVista Pharmaceuticals (KALV) in Q2 2026, closing a stake of 119 shares — an estimated $2.4K sold.

Torren Management first reported a position in KALV in Q4 2025 and held it in 2 quarters. The position peaked at $2.4K in Q1 2026. 1 fund tracked by Wall St. Rank holds KALV as of Q2 2026.

Torren Management reported no remaining KalVista Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Torren Management sold 119 KalVista Pharmaceuticals shares in Q2 2026, an estimated $2.4K.
Torren Management first reported a position in KalVista Pharmaceuticals in Q4 2025 and held it in 2 quarters.
Torren Management's KalVista Pharmaceuticals position peaked at $2.4K in Q1 2026.
1 fund tracked by Wall St. Rank held KalVista Pharmaceuticals as of Q2 2026.

Based on Torren Management's 13F filing for Q2 2026, filed 10 Jul 2026.